Daraxonrasib exhibits ‘encouraging signal’ in RAS-mutant metastatic lung cancertranslating…

An oral drug widely expected to transform pancreatic cancer treatment has demonstrated encouraging clinical activity in metastatic non-small cell lung cancer.

Sign in to join the discussion.

Loading comments…